Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Aug 25, 2020 (6 years ago)

Nature Throid

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Subpotent Drug: FDA analysis found product to be subpotent

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Nature Throid, 3/4 Grain (48.75 mg) Thyroid USP [Liothyronine (T3) 6.75 mcg, Levothyroxine (T4) 28.5 mcg], packaged in a) 100-count bottles (NDC 64727-3302-1) and b) 1000-count bottles (NDC 64727-3302-2), Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

Affected NDCs 64727-3302-01 64727-3302-02

Compare with the code on your package — it is the most precise check available.

Drug: Levothyroxine Category: Thyroid Medication

Recalling firm
RLC Labs Inc.
NDC code
64727-3302-1
Origin
AZ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1616-2020 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Levothyroxine recalls

See all

Other recalls by RLC Labs Inc.

All 2020 recalls
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3305-4 D-1619-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3308-4 D-1618-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3303-1 D-1617-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3299-6 D-1615-2020